Abstract : Tunisian Ministry of Health announced Thursday that the Chinese Sinovac COVID-19 vaccine has been officially approved for marketing in Tunisia.
TUNIS, March 4 (Xinhua) — Tunisian Ministry of Health announced Thursday that the Chinese Sinovac COVID-19 vaccine has been officially approved for marketing in Tunisia.
“The promotion license was granted after evaluating the file submitted by the Chinese laboratory by the National Laboratory for the Control of Medicines and National Center for Pharmacovigilance with the contribution of other experts in the fields of virology, toxicology, immunology and infectious diseases in Tunisia,” said a ministry statement.
“This arrangement will allow the acceleration of the process of acquiring the vaccine,” reads the statement.
Tunisian Health Ministry reported 635 new COVID-19 cases, raising the total number of infections in the country to 235,643.
The death toll from the virus rose by 32 to 8,106, the ministry said in a statement. Enditem
About Xinhua Silk Road
Xinhua Silk Road (en.imsilkroad.com) is the Belt and Road Initiative (BRI) portal.China’s silk road economic belt and the 21st century maritime silk road website,includes BRI Policy, BRI Trade, BRI Investment, Belt and Road weekly, Know Belt and Road, and the integrated information services for the Belt and Road Initiative (BRI).
Source: China’s Sinovac COVID-19 vaccine obtains marketing authorization in Tunisia